Clare Kahn

Biography

  "Dr. Kahn has over 30 years of experience in the pharmaceutical industry with a proven leadership record in drug development, registration and life-cycle. She has held senior roles growing high functioning teams in research and development, regulatory strategy and business development at the portfolio level encompassing small molecules, biologicals and vaccines. Dr. Kahn joined Pfizer in 2010 where she served as Vice President and Head of Global Regulatory Affairs for the $16bn Specialty Care Portfolio before expanding her responsibilities to lead the Global Innovative Pharma Portfolio in 2014. In these roles she drove Pfizer’s global regulatory development for vaccines, anti-infectives, inflammation, rare disease, neuroscience, pain, ophthalmology, cardiovascular, metabolic, renal and gender health. Dr. Kahn joined Pfizer from GlaxoSmithKline (GSK) where she served in preclinical and clinical disposition and metabolism moving into international regulatory affairs and business development. She served in a series of Vice Presidential roles and supported a wide range of therapeutic areas at GSK including pulmonary, anti-infectives, oncology, cardiovascular, metabolic, urology with eleven years in vaccine development. Dr. Kahn has a Ph.D in Biochemical Pharmacology from the Department of Clinical Pharmacology at The Royal Postgraduate Medical School, London and moved to Philadelphia to serve as Assistant Professor in the Departments of Pharmacology and Laboratory Medicine at the University of Pennsylvania. Dr. Kahn served on the Executive Committee of the Graduate Group in Pharmacological Sciences and retained an adjunct faculty position for several years after joining industry."  

Research Interest

preclinical and clinical disposition